Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xifeng Dong

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancers|January 8, 2023
Pim-2 Kinase Regulates Energy Metabolism in Multiple MyelomaZhaoyun Liu, Yixuan Guo, Xiaohan Liu, et al.
Annals of Hematology|April 21, 2025
From severe aplastic anemia with TERT variant to Wilson disease - associations or notTong Chen, Jia Song, Limin Xing, et al.
Hematology (Amsterdam, Netherlands)|June 4, 2026
Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective studyWenya Liu, Yue Ren, Yingao Liang, et al.
Asia-Pacific Journal of Clinical Oncology|June 21, 2021
Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromesXifeng Dong, Yu Han, Yumei Liu, et al.
Thoracic Cancer|March 20, 2025
Aberrant Hematopoiesis and CD8<sup>+</sup> T-Cell Activation in Thymoma-Associated Pure Red Cell AplasiaMengyuan Liu, Xiaoman He, Huiqin Zhang, et al.
Cell Death & Disease|August 9, 2024
CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosisHua Ni, Miao Chen, Dan Dong, et al.
European Journal of Medicinal Chemistry|June 24, 2025
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugatesYan Li, Jian Song, Ruixin Ge, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Nature Communications|March 14, 2025
Identification of a non-inhibitory aptameric ligand to CRL2<sup>ZYG11B</sup> E3 ligase for targeted protein degradationZhihao Yang, Miao Chen, Ruixin Ge, et al.
EMBO Reports|August 29, 2023
HDAC6 deacetylates IDH1 to promote the homeostasis of hematopoietic stem and progenitor cellsJia Yang, Yang Liu, Hanxiao Yin, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancers|January 8, 2023
Pim-2 Kinase Regulates Energy Metabolism in Multiple MyelomaZhaoyun Liu, Yixuan Guo, Xiaohan Liu, et al.
Annals of Hematology|April 21, 2025
From severe aplastic anemia with TERT variant to Wilson disease - associations or notTong Chen, Jia Song, Limin Xing, et al.
Hematology (Amsterdam, Netherlands)|June 4, 2026
Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective studyWenya Liu, Yue Ren, Yingao Liang, et al.
Asia-Pacific Journal of Clinical Oncology|June 21, 2021
Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromesXifeng Dong, Yu Han, Yumei Liu, et al.
Thoracic Cancer|March 20, 2025
Aberrant Hematopoiesis and CD8<sup>+</sup> T-Cell Activation in Thymoma-Associated Pure Red Cell AplasiaMengyuan Liu, Xiaoman He, Huiqin Zhang, et al.
Cell Death & Disease|August 9, 2024
CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosisHua Ni, Miao Chen, Dan Dong, et al.
European Journal of Medicinal Chemistry|June 24, 2025
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugatesYan Li, Jian Song, Ruixin Ge, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Nature Communications|March 14, 2025
Identification of a non-inhibitory aptameric ligand to CRL2<sup>ZYG11B</sup> E3 ligase for targeted protein degradationZhihao Yang, Miao Chen, Ruixin Ge, et al.
EMBO Reports|August 29, 2023
HDAC6 deacetylates IDH1 to promote the homeostasis of hematopoietic stem and progenitor cellsJia Yang, Yang Liu, Hanxiao Yin, et al.
Pageof 3